Literature DB >> 26697838

Skp2 is required for Aurora B activation in cell mitosis and spindle checkpoint.

Juan Wu1, Yu-Fan Huang1, Xin-Ke Zhou2, Wei Zhang3, Yi-Fan Lian3, Xiao-Bin Lv4, Xiu-Rong Gao1, Hui-Kuan Lin5, Yi-Xin Zeng3, Jian-Qing Huang1.   

Abstract

The Aurora B kinase plays a critical role in cell mitosis and spindle checkpoint. Here, we showed that the ubiquitin E3-ligase protein Skp2, also as a cell-cycle regulatory protein, was required for the activation of Aurora B and its downstream protein. When we restored Skp2 knockdown Hela cells with Skp2 and Skp2-LRR E3 ligase dead mutant we found that Skp2 could rescue the defect in the activation of Aurora B, but the mutant failed to do so. Furthermore, we discovered that Skp2 could interact with Aurora B and trigger Aurora B Lysine (K) 63-linked ubiquitination. Finally, we demonstrated the essential role of Skp2 in cell mitosis progression and spindle checkpoint, which was Aurora B dependent. Our results identified a novel ubiquitinated substrate of Skp2, and also indicated that Aurora B ubiquitination might serve as an important event for Aurora B activation in cell mitosis and spindle checkpoint.

Entities:  

Keywords:  Aurora B; Skp2; cell mitosis; genomic stability; spindle checkpoint; tumorigenesis; ubiquitination

Mesh:

Substances:

Year:  2015        PMID: 26697838      PMCID: PMC4825700          DOI: 10.1080/15384101.2015.1120916

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  27 in total

1.  Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis.

Authors:  Szu-Wei Lee; Chien-Feng Li; Chia-Hsin Chan; Jing Wang; Wei-Lei Yang; Ching-Yuan Wu; Juan Wu; Keiichi I Nakayama; Hong-Yo Kang; Hsuan-Ying Huang; Mien-Chie Hung; Pier Paolo Pandolfi; Hui-Kuan Lin
Journal:  Nat Cell Biol       Date:  2010-04-11       Impact factor: 28.824

2.  The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.

Authors:  Ailine Stolz; Norman Ertych; Anne Kienitz; Celia Vogel; Verena Schneider; Barbara Fritz; Ralf Jacob; Gunnar Dittmar; Wilko Weichert; Iver Petersen; Holger Bastians
Journal:  Nat Cell Biol       Date:  2010-04-04       Impact factor: 28.824

3.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

4.  Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1.

Authors:  Juan Wu; Xian Zhang; Ling Zhang; Ching-Yuan Wu; Abdol Hossein Rezaeian; Chia-Hsin Chan; Ju-Mei Li; Jing Wang; Yuan Gao; Fei Han; Yun Seong Jeong; Xiandao Yuan; Kum Kum Khanna; Jianping Jin; Yi-Xin Zeng; Hui-Kuan Lin
Journal:  Mol Cell       Date:  2012-03-29       Impact factor: 17.970

5.  The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.

Authors:  Chia-Hsin Chan; Chien-Feng Li; Wei-Lei Yang; Yuan Gao; Szu-Wei Lee; Zizhen Feng; Hsuan-Ying Huang; Kelvin K C Tsai; Leo G Flores; Yiping Shao; John D Hazle; Dihua Yu; Wenyi Wei; Dos Sarbassov; Mien-Chie Hung; Keiichi I Nakayama; Hui-Kuan Lin
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

Review 6.  Are ubiquitination pathways central to Parkinson's disease?

Authors:  Benoit I Giasson; Virginia M-Y Lee
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

7.  Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression.

Authors:  Chia-Hsin Chan; John Kenneth Morrow; Chien-Feng Li; Yuan Gao; Guoxiang Jin; Asad Moten; Loren J Stagg; John E Ladbury; Zhen Cai; Dazhi Xu; Christopher J Logothetis; Mien-Chie Hung; Shuxing Zhang; Hui-Kuan Lin
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

8.  The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint.

Authors:  Silke Hauf; Richard W Cole; Sabrina LaTerra; Christine Zimmer; Gisela Schnapp; Rainer Walter; Armin Heckel; Jacques van Meel; Conly L Rieder; Jan-Michael Peters
Journal:  J Cell Biol       Date:  2003-04-21       Impact factor: 10.539

9.  CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis.

Authors:  S G Zeitlin; R D Shelby; K F Sullivan
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

10.  Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores.

Authors:  Claire Ditchfield; Victoria L Johnson; Anthony Tighe; Rebecca Ellston; Carolyn Haworth; Trevor Johnson; Andrew Mortlock; Nicholas Keen; Stephen S Taylor
Journal:  J Cell Biol       Date:  2003-04-28       Impact factor: 10.539

View more
  7 in total

1.  Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.

Authors:  Wenwen Zhang; Lulu Cao; Zijia Sun; Jing Xu; Lin Tang; Weiwei Chen; Jiayan Luo; Fang Yang; Yucai Wang; Xiaoxiang Guan
Journal:  Cell Cycle       Date:  2016-04-25       Impact factor: 4.534

Review 2.  F-Box Proteins and Cancer.

Authors:  Kanae Yumimoto; Yuhei Yamauchi; Keiichi I Nakayama
Journal:  Cancers (Basel)       Date:  2020-05-15       Impact factor: 6.639

3.  The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma.

Authors:  Hongmei Cui; Qinghui Wang; Duane D Miller; Wei Li
Journal:  Front Pharmacol       Date:  2021-03-25       Impact factor: 5.810

4.  Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation.

Authors:  Adnan Erol
Journal:  Cancer Manag Res       Date:  2022-08-05       Impact factor: 3.602

Review 5.  Emerging Roles of SKP2 in Cancer Drug Resistance.

Authors:  Ting Wu; Xinsheng Gu; Hongmei Cui
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

Review 6.  The Skp2 Pathway: A Critical Target for Cancer Therapy.

Authors:  Zhen Cai; Asad Moten; Danni Peng; Che-Chia Hsu; Bo-Syong Pan; Rajeshkumar Manne; Hong-Yu Li; Hui-Kuan Lin
Journal:  Semin Cancer Biol       Date:  2020-02-01       Impact factor: 17.012

7.  CACYBP Enhances Cytoplasmic Retention of P27Kip1 to Promote Hepatocellular Carcinoma Progression in the Absence of RNF41 Mediated Degradation.

Authors:  Yi-Fan Lian; Yan-Lin Huang; Yao-Jun Zhang; Dong-Mei Chen; Jia-Liang Wang; Huan Wei; Yan-Hua Bi; Zhi-Wu Jiang; Peng Li; Min-Shan Chen; Yue-Hua Huang
Journal:  Theranostics       Date:  2019-10-22       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.